DECIPHER LABS last traded at ₹5.80 (2026-10-13). Over the past month the stock moved +1.8%, three months the stock moved -20.5%, year the stock moved -44.5%. Its closing range over 52 weeks is ₹5.33 – ₹10.20, with the latest close 43.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.[1]
Business Overview:[1] DCL is in the business of: a) Pharma: Manufacturing and trading of Pharmaceutical products b) Consultancy: It also provides consultancy services
In the latest quarter (Jun 2026), DECIPHER LABS reported sales of ₹2.41 crore (-17.5%) and net profit of ₹-2.19 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 2.41 | -2.16 | -89.63 | -2.19 | -2.17 |
| Mar 2026 | 3.60 | 0.23 | 6.39 | -0.36 | -0.36 |
| Dec 2025 | 3.21 | -0.43 | -13.40 | -0.54 | -0.53 |
| Sep 2025 | 4.31 | 0.12 | 2.78 | 0.02 | 0.02 |
| Jun 2025 | 2.92 | -3.32 | -113.70 | -3.43 | -3.40 |
| Mar 2025 | 3.50 | -6.58 | -188.00 | -4.11 | -4.07 |
| Dec 2024 | 5.80 | -0.63 | -10.86 | -0.59 | -0.58 |
| Sep 2024 | 5.87 | -1.33 | -22.66 | -1.33 | -1.32 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -21.6% | -30.0% | -66.9% | -60.8% | -26.6% | -44.7% | +2.9% | -17.5% |
| Operating profit growth | – | -584.6% | -643.8% | -353.4% | – | – | – | – |
| Net profit growth | – | -6000.0% | -442.5% | -461.1% | – | – | – | – |
| EPS growth | – | -5900.0% | -442.0% | -461.7% | – | – | – | – |
| OPM % | -22.7% | -10.9% | -188.0% | -113.7% | 2.8% | -13.4% | 6.4% | -89.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), DECIPHER LABS reported sales of ₹14.05 crore (-37.9%) and net profit of ₹-3.08 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 14.05 | -3.39 | -24.13 | -3.08 | -3.05 |
| Mar 2025 | 22.61 | -7.23 | -31.98 | -5.08 | -5.03 |
| Mar 2024 | 35.88 | -0.68 | -1.90 | -1.68 | -1.66 |
| Mar 2023 | 45.57 | -4.17 | -9.15 | -2.68 | -2.65 |
| Mar 2022 | 65.32 | 6.03 | 9.23 | 11.38 | 11.27 |
| Mar 2021 | 55.56 | 3.48 | 6.26 | 1.40 | 1.39 |
| Mar 2020 | 23.99 | 2.52 | 10.50 | 1.10 | 1.09 |
| Mar 2019 | 8.06 | 0.45 | 5.58 | 0.41 | 0.51 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +690.2% | +197.6% | +131.6% | +17.6% | -30.2% | -21.3% | -37.0% | -37.9% |
| Operating profit growth | +542.9% | +460.0% | +38.1% | +73.3% | -169.2% | – | – | – |
| Net profit growth | +127.8% | +168.3% | +27.3% | +712.9% | -123.6% | – | – | – |
| EPS growth | +131.8% | +113.7% | +27.5% | +710.8% | -123.5% | – | – | – |
| OPM % | 5.6% | 10.5% | 6.3% | 9.2% | -9.2% | -1.9% | -32.0% | -24.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for DECIPHER LABS.
Get Free AI Stock Analysis FREE →Decipher Labs reports consolidated net loss of Rs 2.19 crore in the June 2026 quarter - Business Standard
DECIPHER LABS shares were last quoted at ₹5.80 (-1.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
DECIPHER LABS has a price-to-earnings (P/E) ratio of -15.79 and a price-to-book (P/B) ratio of 1.00. The industry P/E is 52.82.
The 52-week high of DECIPHER LABS is ₹10.99 and the 52-week low is ₹5.00.
The market capitalisation of DECIPHER LABS is about ₹6.06 crore.
In the latest quarter (Jun 2026), DECIPHER LABS reported sales of ₹2.41 crore (-17.5%) and net profit of ₹-2.19 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, DECIPHER LABS has a 3-year ROE of -7.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 16.43% of DECIPHER LABS.
DECIPHER LABS belongs to the Pharmaceuticals & Drugs sector.